Clinical Trials Logo

Clinical Trial Summary

The PRO Health Study is a single-center, prospective, double-blind, randomized, placebo-controlled trial of streptococcus-containing supplementation in healthy adults.


Clinical Trial Description

Upon enrollment, healthy adults will enter a 1-week lead-in period which serves as an opportunity to collect baseline saliva samples and complete daily logs. Subjects that meet eligibility criteria on Day 7 will be randomized into 1 of 2 groups, receiving either a placebo-control or a streptococcus-containing probiotic supplement. Supplementation will begin on Day 8 and will continue for a total of 14 consecutive days. Participants will be observed for an additional 2 weeks following cessation of supplementation. The total duration of the study will be approximately 5 weeks. Saliva samples will be collected on 7 occasions and participants will be asked to complete questionnaires and daily diet and health logs throughout the course of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03748017
Study type Interventional
Source University of California, Davis
Contact
Status Completed
Phase N/A
Start date September 4, 2018
Completion date October 1, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04139538 - Microbiome and Immunogenity of Saliva During Orthodontic Therapy N/A
Completed NCT05672953 - Biogeography of the Oral Microbiome
Recruiting NCT04993846 - Pancreatic Cancer and Oral Microbiome
Completed NCT05270382 - Effect of Mouthwashes on Oral Wound Healing and Microbiome N/A